Heme oxygenase-1 gene expression modulates angiotensin II-induced increase in blood pressure

Hypertension

Volumn 43, Issue 6, 2004, Pages 1221-1226

  Yang, Liming ^a   Quan, Shuo ^a   Nasjletti, Alberto ^a   Laniado Schwartzman, Michal ^a   Abraham, Nader G ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Angiotensin II; Blood pressure; Genes; Oxidative stress; Retrovirus

Indexed keywords

ANGIOTENSIN; HEME OXYGENASE 1; MESOPORPHYRIN TIN; MESSENGER RNA; RETROVIRUS VECTOR;

ANIMAL EXPERIMENT; ARTERY CATHETER; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; FEMORAL ARTERY; GENE EXPRESSION; HEART LEFT VENTRICLE; INTRAVENOUS CATHETER; MEAN ARTERIAL PRESSURE; NEWBORN; NONHUMAN; NUCLEIC ACID PROBE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; CARBON MONOXIDE; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HUMANS; KIDNEY; MEMBRANE PROTEINS; OLIGONUCLEOTIDES, ANTISENSE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRANSDUCTION, GENETIC; VASOCONSTRICTION;

EID: 2542434044     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000126287.62060.e6     Document Type: Article

References (40)

1. Abraham NG, Lin JH, Schwartzman ML, Levere RD, Shibahara S. The physiological significance of heme oxygenase. Int J Biochem. 1988;20:543-558.
2. Maines MD. The heme oxygenase system; a regulator of second messenger gases. Ann Rev Pharmacol Toxicol. 1997;37:517-554.
3. Johnson RA, Lavesa M, Askari B, Abraham NG, Nasjletti A. A heme oxygenase product, presumably carbon monoxide, mediates a vasodepressor function in rats. Hypertension. 1995;25:166-169.
4. Kaide JI, Zhang F, Wei Y, Jiang H, Yu C, Wang WH, Balazy M, Abraham NG, Nasjletti A. Carbon monoxide of vascular origin attenuates the sensitivity of renal arterial vessels to vasoconstrictors. J Clin Invest. 2001;107:1163-1171.
5. Brune B, Ullrich V. Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. Mol Pharmacol. 1987;32:497-504.
6. Morita T, Perrella MA, Lee M, Kourembanas S. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci U S A. 1995;92:1475-1479.
7. Coceani F, Kelsey L, Seidlitz E. Carbon monoxide-induced relaxation of the ductus arteriosus in the lamb: evidence against the prime role of guanylyl cyclase. Br J Pharmacol. 1996;118:1689-1696.
8. Wang R, Wang Z, Wu L. Carbon monoxide-induced vasorelaxation and the underlying mechanisms. Br J Pharmacol. 1997;121:927-934.
9. Johnson RA, Lavesa M, DeSeyn K, Scholer MJ, Nasjletti A. Heme oxygenase substrates acutely lower blood pressure in hypertensive rats. Am J Physiol. 1996;271:H1132-H1138.
10. Haugen EN, Croatt AJ, Nath KA. Angiotensin II induces renal oxidant stress in vivo and heme oxygenase-1 in vivo and in vitro. Kidney Int. 2000;58:144-152.
11. Ishizaka N, Aizawa T, Mori I, Taguchi J, Yazaki Y, Nagai R, Ohno M. Heme oxygenase-1 is upregulated in the rat heart in response to chronic administration of angiotensin II. Am J Physiol Heart Circ Physiol. 2000;279:H672-H678.
12. Ishizaka N, Aizawa T, Ohno M, Usui SS, Mori I, Tang SS, Ingelfinger JR, Kimura S, Nagai R. Regulation and localization of HSP70 and HSP25 in the kidney of rats undergoing long-term administration of angiotensin II. Hypertension. 2002;39:122-128.
13. Ishizaka N, De Leon H, Laursen JB, Fukui T, Wilcox JN, De Keulenaer G, Griedling KK, Alexander RW. Angiotensin II-induced hypertension increases heme oxygenase-1 expression in rat aorta. Circulation. 1994;96:1923-1929.
14. Datta PK, Moulder JE, Fish BL, Cohen EP, Lianos EA. Induction of heme oxygenase 1 in radiation nephropathy: role of angiotensin II. Radiat Res. 2001;155:734-739.
15. Ishizaka N, Griedling KK. Heme oxygenase-2 is regulated by angiotensin II in rat vascular smooth muscle cells. Hypertension. 1997;29:790-795.
16. da-Silva JL, Tiefenthaler M, Park E, Escalante B, Schwartzman ML, Levere RD, Abraham NG. Tin-mediated heme oxygenase gene activation and cytochrome P450 arachidonate hydroxylase inhibition in spontaneously hypertensive rats. [published erratum appears in Am J Med Sci 1994 Aug;308(2):138]. Am J Med Sci. 1994;307:173-181.
17. da-Silva JL, Tiefenthaler M, Park E, Escalante B, Schwartzman ML, Levere RD, Abraham NG. Tin-mediated heme oxygenase gene activation and cytochrome P450 arachidonate hydroxylase inhibition in spontaneously hypertensive rats. [published erratum appears in Am J Med Sci 1994 Aug;308(2):138]. Am J Med Sci. 1994;307:173-181.
18. Laniado-Schwartzman M, Abraham NG, Sacerdoti D, Escalante B, McGiff JC. Effect of acute and chronic treatment of tin on blood pressure in spontaneously hypertensive rats. Tohoku J Exp Med. 1992;166:85-91.
19. Sacerdoti D, Escalante B, Abraham NG, McGiff JC, Levere RD, Schwartzman ML. Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. Science. 1989;243:388-390.
20. Sabaawy HE, Zhang F, Nguyen X, Elhosseiny A, Nasjletti A, Schwartzman M, Dennery P, Kappas A, Abraham NG. Human heme oxygenase-1 gene transfer lowers blood pressure and promotes growth in spontaneously hypertensive rats. Hypertension. 2001;38:210-215.
21. Yang L, Quan S, Abraham NG. Retrovirus-mediated HO gene transfer into endothelial cells protects against oxidant-induced injury. Am J Physiol. 1999;277:L127-L133.
22. Shibahara S, Muller R, Taguchi H, Yoshida T. Cloning and expression of cDNA for rat heme oxygenase. Proc Natl Acad Sci U S A. 1985;82:7865-7869.
23. Chernick RJ, Martasek P, Levere RD, Margreiter R, Abraham NG. Sensitivity of human tissue heme oxygenase to a new synthetic metalloporphyrin. Hepatology. 1989;10:365-369.
24. Quan S, Yang L, Abraham NG, Kappas A. Regulation of human heme oxygenase in endothelial cells by using sense and antisense retroviral constructs. Proc Natl Acad Sci U S A. 2001;98:12203-12208.
25. Quan S, Yang L, Shenouda S, Jiang H, Balazy M, Schwartzman ML, Shibahara I, Shinohara K, Abraham NG. Functional expression of human heme oxygenase-1 (HO-1) driven by HO-1 promoter in vitro and in vivo. J Cell Biochem. 2002;85:1-12.
26. Kushida T, Li VG, Quan S, Goodman A, Abraham NG. Role of human heme oxygenase-1 in attenuating TNF-alpha-mediated inflammation injury in endothelial cells. J Cell Biochem. 2002;87:377-385.
27. Abraham N. G., Kushida T., McClung J, Quan S, Lafaro R, Darzynkiewicz Z, Wolin MS. Heme oxygenase-1 attentuates glucose mediated cell growth arrest and apoptosis in human microvessel endothelial cells. Circ Res. 2003;93:131-139.
28. Martens JR, Reaves PY, Lu D, Katovich MJ, Bereck KH, Bishop SP, Raizada MK, Gelband CH. Prevention of renovascular and cardiac pathophysiological changes in hypertension by angiotensin II type 1 receptor antisense gene therapy. Proc Natl Acad Sci U S A. 1998;95:2664-2669.
29. Botros FT, Laniado-Schwartzman M, Abraham NG. Regulation of cyclooxygenase- and cytochrome p450-derived eicosanoids by heme oxygenase in the rat kidney. Hypertension. 2002;39:639-644.
30. Kozma F, Johnson RA, Zhang F, Yu C, Tong X, Nasjletti A. Contribution of endogenous carbon monoxide to regulation of diameter in resistance vessels. Am J Physiol. 1999;276:R1087-R1094.
31. Wolf G. Free radical production and angiotensin. Curr Hypertens Rep. 2000;2:167-173.
32. Haider A, Olszanecki R, Gryglewski R, Schwartzman ML, Lianos E, Kappas A, Nasjletti A, Abraham NG. Regulation of cyclooxygenase by the heme-heme oxygenase system in microvessel endothelial cells. J Pharmacol Exp Ther. 2002;300:188-194.
33. Li Volti G, Seta F, Schwartzman ML, Nasjletti A, Abraham NG. Heme oxygenase attenuates angiotensin II-mediated increase in cyclooxygenase-2 activity in human femoral endothelial cells. Hypertension. 2003;41:715-719.
34. Lin L, Balazy M, Pagano PJ, Nasjletti A. Expression of prostaglandin H2-mediated mechanism of vascular contraction in hypertensive rats. Relation to lipoxygenase and prostacyclin synthase activities. Circ Res. 1994;74:197-205.
35. Wilcox CS, Welch WJ. Thromboxane mediation of the pressor response to infused angiotensin II. Am J Hypertens. 1990;3:242-249.
36. Sessa WC, Abraham NG, Escalante B, Schwartzman ML. Manipulation of cytochrome P-450 dependent renal thromboxane synthase activity in spontaneously hypertensive rats. J Hypertens. 1989;7:37-42.
37. Abraham NG. Therapeutic applications of human heme oxygenase gene transfer and gene therapy. Curr Pharm Des. 2003;9:2513-2524.
38. Abraham NG, Olszanecki R. Cyclooxygenase activity is regulated by the heme oxygenase system in microvessel endothelial cells. Adv Exp Med Biol. 2003;525:59-66.
39. Abraham NG, Mieyal PA, Quan S, Yang L, Burke-Wolin T, Mingone CJ, Goodman AI, Nasjletti A, Wolin MS. Modulation of cyclic GMP by retrovirus-mediated human heme oxgyenase-1 gene transfer in microvessel endothelial cells. Am J Physiol. 2002;283:L1117-L1124.
40. Aizawa T, Ishizaka N, Taguchi J, Nagai R, Mori I, Tang SS, Ingelfinger JR, Ohno M. Heme oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats: possible role in renoprotection. Hypertension. 2000;35:800-806.